Question 1

What are the potential benefits of using the rivastigmine patch for my Alzheimer's?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease clinical trial (NCT00099242). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of while using this patch?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease clinical trial (NCT00099242). Contact the study team or your healthcare provider for specific answers.

Question 3

How will this treatment fit with my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease clinical trial (NCT00099242). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will be required during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease clinical trial (NCT00099242). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with using this patch?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease clinical trial (NCT00099242). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my caregiver be involved in the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease clinical trial (NCT00099242). Contact the study team or your healthcare provider for specific answers.

What this study is about